In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

Shares of Cloudflare Inc. (NET) fell nearly 1% in after-market trade on Monday, extending the losses of 1.6% during the day’s ...

Fintel reports that on March 3, 2025, Piper Sandler upgraded their outlook for ACNB (NasdaqCM:ACNB) from Neutral to ...

Leerink Partners and Piper Sandler are acting as joint bookrunning managers for the proposed offering.

The U.S. economy has proved pessimists wrong so many times, it’s tempting to think nothing can stop it. President Trump’s ...

Looking at more recent history, Kantrowitz noted that every correction from the late 1990s until 2018 "were all growth-driven market corrections." The two since 2022 have been rates-driven selloffs, ...

The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...

Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the ...

Nvidia Corp.'s stock still looks good to many Wall Street analysts ahead of the artificial-intelligence chip maker's earnings Wednesday, even though the company isn't expected to report the same level ...